A First-In-Human Randomized, Double-Blind, Placebo-Controlled, Single- And Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 to Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.03478-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: A Randomized, Placebo-Controlled First-In-Human Single-Dose Escalation Study

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2017English

A Randomized, Placebo-Controlled, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2018English

A Phase I, Placebo-Controlled, Randomized, Double-Blind, Single Ascending Dose-Ranging Study to Evaluate the Safety and Tolerability of a Novel Biophysical Bronchodilator (S-1226) Administered by Nebulization in Healthy Volunteers

Trials
MedicinePharmacology
2016English

Safety, Tolerability and Efficacy of Intra-Articular Progenza in Knee Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Single Ascending Dose Study

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Correction To: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-In-Human, Single- And Multiple-Dose Study in Healthy Volunteers

Clinical Drug Investigation
MedicinePharmacology
2019English

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Dose JPI-289, a Novel Poly (ADP-Ribose) Polymerase-1 Inhibitor in First-In-Human Study of Healthy Volunteers

Clinical Therapeutics
Pharmacology
2017English

Single and Multiple Dose Pharmacokinetics And tolerability of HX-1171, a Novel Antioxidant, in Healthy Volunteers

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Safety, Tolerability and Pharmacokinetics of Higher-Dose Mizoribine in Healthy Male Volunteers

British Journal of Clinical Pharmacology
Pharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy